Cell line · CVCL_1379
LNCaP clone FGC
Cancer cell line, Homo sapiens. Prostate carcinoma. 70 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. LNCaP clone FGC. Cell lines, record CVCL_1379. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1379
On this page
Cell line
As Cellosaurus gives it.
- Name
- LNCaP clone FGC
- Accession
- CVCL_1379
- RRID
- RRID:CVCL_1379
- Synonyms
- LNCaP-Clone-FGC, LNCaP.FGC, LNCaP-FGC, LNCaP FGC, LNCAPCLONEFGC, LNCaP-ATCC, LNCaP Fast Growing Colony
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 50Y
- Category
- Cancer cell line
- Diseases
- Prostate carcinoma (NCIt C4863)
- Derived from
- Left supraclavicular lymph node (metastatic)
- Parent
- LNCaP (CVCL_0395)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers70
43 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Vitronectin Enrichment in Prostate Cancer Liver Metastases Promotes Adhesion and Survival. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Spatiotemporal Atlas of the Androgen Receptor Proximal Interactome. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multi-omics dissection of FOXA1 reveals cancer-type-specific transcriptional networks and functional risk variants. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ERG Orchestrates a Dedifferentiation-Senescence-Inflammation Triad in Prostate Cancer. | Mol Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Molecular Design and Preclinical Evaluation of GenSci143, a Novel B7-H3-Directed and PSMA-Directed Bispecific Antibody-Drug Conjugate, for the Treatment of Prostate Cancer. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PVT1 lincRNA signals an androgen-dependent transcriptional activation program of oncogenes in prostate cancer cells. | Int J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GNL3 Orchestrates AR Transcriptional Programs to Drive Castration-Resistant Prostate Cancer and Immune Evasion. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Increasing Cancer Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 70
See all 70 papersRelatives23
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | LNCaP | CVCL_0395 | Cell lines | |
| Derived from it | AILNCaP | CVCL_U984 | Cell lines | |
| Derived from it | Abcam LNCaP clone FGC TMPRSS2 KO | CVCL_C0BI | Cell lines | |
| Derived from it | JHU-LNCaP-SM | CVCL_C0Z9 | Cell lines | |
| Derived from it | LNCAP-AAR | CVCL_ZX07 | Cell lines | |
| Derived from it | LNCaP AR-NTD/pHage | CVCL_A1BN | Cell lines | |
| Derived from it | LNCaP AR-V7/pHage | CVCL_A1BM | Cell lines | |
| Derived from it | LNCaP AR-V7/pLenti | CVCL_A1BL | Cell lines | |
| Derived from it | LNCaP Clone FGC-EGFP | CVCL_C8W7 | Cell lines | |
| Derived from it | LNCaP clone FGC(Cas9) | CVCL_E7J8 | Cell lines |
1 to 10 of 23
See all 23 relativesCell banks14
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1740 | ATCC | |
| Abcam | ab275470 | Abcam | |
| AddexBio | C0019003/4953 | Cellosaurus | |
| BCRC | 60088 | BCRC | |
| BCRJ | 0149 | BCRJ | |
| CLS | 305220 | CLS | |
| ECACC | 89110211 | ECACC | |
| ICLC | HTL99011 | ICLC | |
| IZSLER | BS TCL 148 | Cellosaurus | |
| KCB | KCB 200732YJ | Cellosaurus |
1 to 10 of 14
See all 14 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1379
GET https://conductscience.org/api/cell-lines/v1/CVCL_1379/papers?page=2